Health
Moderna, Merck Fall After Melanoma Data Leak
Key Points
Oct 22nd, 2026 Moderna, Merck Fall After Melanoma Data Leak Moderna and Merck shares plummeted after data on the companies' personalized melanoma vaccine wasn't enough to prove to investors that a new era of cancer treatments has arrived. Michelle Fay Cortez has more on "Bloomberg The Close."
Oct 22nd, 2026
Moderna, Merck Fall After Melanoma Data Leak
Moderna and Merck shares plummeted after data on the companies' personalized melanoma vaccine wasn't enough to prove to investors that a new era of cancer treatments has arrived. Michelle Fay Cortez has more on "Bloomberg The Close."